This study aims to determine whether referral to the Bridge Clinic reduces overall index hospital length of stay when compared to direct referral to a long-term outpatient addiction provider for patients with active opioid use disorder (OUD) being considered for medications-for-addiction treatment (MAT).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Enrollment
335
Referral to the Bridge Clinic for temporary outpatient addiction treatment while the bridge clinic identifies an outpatient addiction treatment provider to accept the patient for long term treatment.
Referral to an outpatient provider for addiction treatment.
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Hospital Length of Stay
Overall index hospital length of stay measured in days
Time frame: approximately 3 to 42 days
Combined Cost of Index Admission and Subsequent Admissions During the Study Period
Total costs, and costs for each admission and care resource used measured in dollars. This includes the cost of the index hospital admission along with any subsequent admissions during the 16-week follow up period.
Time frame: 16 weeks post-randomization
Number of Participants With Successful Care Linkage
Dichotomous self-reported outcome of linkage to a MAT provider as defined by attending at least one visit with a MAT provider
Time frame: 16 weeks post-randomization
Number of MAT Prescriptions Filled by Participant
Reported buprenorphine-naloxone (or naltrexone) prescriptions filled
Time frame: 16 weeks post-randomization
Readmissions and Emergency Department (ED) Visits
Composite number of ED visits and readmissions
Time frame: 16 weeks post-randomization
Hospital and ED Free Days
Days alive out of the hospital and/or ED
Time frame: 16 weeks post-randomization
Mortality
Death in hospital or documented at 16-week follow up or in the medical record.
Time frame: 16 weeks post-randomization
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Recurrent Opioid Use
The number of participants with recurrent opioid use.
Time frame: 16 weeks post-randomization
Overdose
Any overdose self-reported at the 16-week follow up
Time frame: 16 weeks post-randomization
Quality of Life - Schwartz Outcome Scale-10 (SOS10).
The Quality of Life - Schwartz Outcome Scale-10 (SOS10) survey has ten questions scored on a 0 (never) to 6 (all or nearly all of the time) scale that measures the broad domain of psychological well-being and quality of life. A total score is computed as the sum across the 10 questions. Therefore, the minimum total score is 0 (never) and the maximum score is 60 (all or nearly all of the time). Higher scores indicate greater well-being and psychological health. Therefore, higher scores are better.
Time frame: 16 weeks post-randomization
Opioid Use Within 30 Days
Opioid use within 30 days as self-reported and assessed during the 16-week follow up phone call.
Time frame: 30 days